Ultralife Corporation
ULBI · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 3.7% | 20.3% | 34.2% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 25.7% | 24.7% | 22.3% | 25.1% |
| EBITDA | $0 | $0 | $0 | $0 |
| % Margin | 8.8% | 9.5% | 3.8% | 3.7% |
| Net Income | $0 | $0 | -$0 | -$0 |
| % Margin | 3.8% | 4.5% | -0.1% | -0.2% |
| EPS Diluted | 0.38 | 0.44 | -0.007 | -0.015 |
| % Growth | -13.6% | 6,045.9% | 49.3% | – |
| Operating Cash Flow | $0 | $0 | -$0 | $0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | $0 | -$0 | -$0 | $0 |